1 / 24

Presentation to: 2007 HIV Diagnostics Conference Atlanta, December 5-7, 2007

Results of a Pilot Point-of-Care (POC) HIV Testing Program using INSTI HIV in an Urban Sexual Health Clinic in Canada. Presentation to: 2007 HIV Diagnostics Conference Atlanta, December 5-7, 2007. Hassle Free Clinic, Toronto. Community-based inner city sexual health clinic (1973)

gudrun
Download Presentation

Presentation to: 2007 HIV Diagnostics Conference Atlanta, December 5-7, 2007

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Results of a Pilot Point-of-Care (POC) HIV Testing Program using INSTI HIV in an Urban Sexual Health Clinic in Canada Presentation to: 2007 HIV Diagnostics Conference Atlanta, December 5-7, 2007

  2. Hassle Free Clinic, Toronto • Community-based inner city sexual health clinic (1973) • Funded by City of Toronto, Ontario Ministry of Health and Long-term Care (MOHLTC) and donations • Approximately 18,000 client visits per year (non HIV) • Offers anonymous HIV testing (since 1985) • Legislated in 1992, guidelines developed by MOH • Voluntary testing, counseling and reporting system • >5000 tests per year • First Canadian clinic to offer HIV Point of Care testing • Male (70%) • Female (30%)

  3. Rationale for HIV POC testing • Uptake and access – high client and provider satisfaction • Requires only one appointment for pre and post-test counseling for non-reactive results (>98%) • Ensures continuity with client • Better reinforcement of harm reduction strategies • Increased acceptance of negative results • Easier to deliver preliminary reactive results • Follow-up appointment for confirmatory results • May require additional support during wait period • If high risk, clinic begins referral process before confirmatory • Increased clinic capacity (25% more clients), better workflow

  4. INSTI HIV Test • Produced by bioLytical Laboratories Inc., Richmond, BC • 2 years of Canadian clinical trials, 16,000 tests • Licensed as Class IV Medical Device by Health Canada, 2005 • CE Marked • USAID PEPFAR waiver listed Package insert performance characteristics • Sensitivity (fingerstick) 99.6% [CI 98.9 – 99.5%] • Specificity (fingerstick) 99.3% [CI 98.9 – 99.5%]

  5. 1 1 2 2 INSTI Test System IgG capture/ blue labeled Control Spot Human IgG IgG capture IgG capture/ blue labeled Anti-HIV 1/2 Test Spot HIV 1/2 Antigens

  6. INSTI Procedure:

  7. INSTI Procedure… Add Developer (2)

  8. INSTI Procedure… Add Clarifying Solution (3)

  9. INSTI Interpretation • NON-REACTIVE: • One blue dot, clearly discernible above any background tint on the membrane. • This is the IgG Control Spot: shows test has been performed correctly and sample has been added. • The control is located towards the top of the read frame, furthest from the plastic tab on the Membrane Unit. • No reaction should be visible at the test spot, located below the control. • This result indicates antibodies to HIV-1/HIV-2 were not detected. CONTROL TAB

  10. INSTI Interpretation…2 • REACTIVE: • Two blue dots discernible above any background tint indicate possible presence of HIV-1/HIV-2 antibodies. • One dot may be darker than the other. • A sample giving this pattern is considered a preliminary reactive. • Following a reactive rapid test result, a venous blood sample must be drawn for laboratory-based confirmatory testing. CONTROL CONTROL CONTROL TEST TEST TEST TAB TAB TAB

  11. TAB TAB TEST INVALID results: A. There is no dot on the membrane B. The test dot appears without the control dot Recommendation: INVALID tests with finger-stick blood samples in POC settings should be repeated with a fresh sample using a new membrane unit, kit components, and support materials. INSTI Interpretation…3

  12. INSTI Interpretation…4 • The test is INDETERMINATE if a faint background ring appears on the test area. • Following an indeterminate test result, a venous blood sample must be drawn in an EDTA collection tube (for whole blood or plasma) or red-top tube (for serum), and forwarded to a laboratory for HIV confirmatory testing. CONTROL TEST TAB INDETERMINATE:

  13. Objective • To evaluate the efficacy of HIV POC testing at Hassle Free Clinic • To set standards of care for HIV POC testing • To monitor client uptake and satisfaction • To evaluate provider satisfaction

  14. Methods • Clients attending HFC for anonymous HIV testing were offered routine lab based or POC testing during pre-test counseling • Routine HIV testing was performed by the Central Public Health Laboratory (CPHL) • POC testing was done using INSTI HIV • POC Negative clients received post-test counseling • POC Reactive clients were counseled and offered lab-based confirmatory testing • Confirmatory testing (EIA, p24, WB) was done STAT by CPHL • Final post-test counseling and referrals in 1-2 weeks

  15. Results • Between May 15, 2006 and September 30, 2007 • 6545 clients attended HFC for HIV anonymous testing • 4721 Male (53% MSM, <1% High Risk Heterosexual (HRH)) • 1824 Female ( 8% HRH, <1% IDU)

  16. Results – Proportion choosing POC • Males – 96.5% (4560/4721) • Females – 87.1% (1615/1824) • Overall – 94.3% (6175/6545)

  17. Results – POC Testing

  18. Results – Follow-up testing Males – 78 Reactive + 10 Indeterminate = 88 81 accepted confirmatory testing 7 declined follow-up testing • 5 had a previous HIV diagnosis • 1 opted to go to primary care physician for confirmatory • 1 declined confirmatory Females – 7 Reactive + 2 Indeterminate = 9 8 accepted confirmatory testing 1 declined follow-up testing • 1 had a previous HIV diagnosis

  19. Results – Confirmatory Testing for POC Reactive Clients

  20. Conclusions - INSTI Performance • Specificity 6079/6087 x 100 = 99.85% [CI 99.7-99.9] • Positive Predictive Value 80/89 x 100 = 89.89%

  21. Conclusions • Based on HFC experience and INSTI HIV performance, the MOH is expanding rapid HIV POC testing to 60 anonymous HIV and sexual health clinics in Ontario • Implementation includes new counseling guidelines, training for providers, rigorous quality assurance policies and procedures including kit controls and external quality assessment, and a system to collect epi data on all testers. • Anticipated volume – 60,000 tests per year

  22. Acknowledgements Hassle Free Clinic • Jane Greer, Leo Mitterni, Craig Stephen, Amy Lin AIDS Bureau, Ontario Ministry of Health and Long-term Care • Frank McGee • Ken English Public Health Laboratories • Carol Swantee Ontario HIV Treatment Network • Carol Major McMaster University • Bethany Henrick

More Related